REF_AREA stringclasses 54
values | Geographic area stringclasses 54
values | INDICATOR stringclasses 13
values | Indicator stringclasses 13
values | SEX stringclasses 1
value | Sex stringclasses 1
value | TIME_PERIOD int64 1.98k 2.02k | OBS_VALUE int64 0 100 | UNIT_MULTIPLIER int64 0 0 | Unit multiplier stringclasses 1
value | UNIT_MEASURE stringclasses 1
value | Unit of measure stringclasses 1
value | OBS_STATUS stringclasses 1
value | Observation Status stringclasses 1
value | OBS_FOOTNOTE stringclasses 2
values | DATA_SOURCE stringclasses 2
values | AGE stringclasses 4
values | Current age stringclasses 4
values |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ZAF | South Africa | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,015 | 85 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZAF | South Africa | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,016 | 82 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZAF | South Africa | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,017 | 78 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZAF | South Africa | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,018 | 82 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZAF | South Africa | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,019 | 85 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZAF | South Africa | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,020 | 82 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZAF | South Africa | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,021 | 86 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZAF | South Africa | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,022 | 88 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZAF | South Africa | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,023 | 83 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZAF | South Africa | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,024 | 81 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
SDN | Sudan | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,013 | 30 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
SDN | Sudan | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,014 | 97 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
SDN | Sudan | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,015 | 93 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
SDN | Sudan | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,016 | 93 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
SDN | Sudan | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,017 | 95 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
SDN | Sudan | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,018 | 93 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
SDN | Sudan | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,019 | 93 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
SDN | Sudan | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,020 | 90 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
SDN | Sudan | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,021 | 85 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
SDN | Sudan | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,022 | 83 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
SDN | Sudan | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,023 | 52 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
SDN | Sudan | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,024 | 40 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TGO | Togo | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,014 | 25 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TGO | Togo | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,015 | 77 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TGO | Togo | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,016 | 82 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TGO | Togo | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,017 | 84 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TGO | Togo | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,018 | 82 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TGO | Togo | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,019 | 85 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TGO | Togo | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,020 | 84 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TGO | Togo | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,021 | 86 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TGO | Togo | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,022 | 85 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TGO | Togo | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,023 | 89 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TGO | Togo | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,024 | 89 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TUN | Tunisia | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,020 | 87 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TUN | Tunisia | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,021 | 96 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TUN | Tunisia | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,022 | 98 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TUN | Tunisia | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,023 | 97 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TUN | Tunisia | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,024 | 97 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
UGA | Uganda | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,014 | 60 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
UGA | Uganda | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,015 | 64 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
UGA | Uganda | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,016 | 77 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
UGA | Uganda | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,017 | 90 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
UGA | Uganda | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,018 | 92 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
UGA | Uganda | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,019 | 92 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
UGA | Uganda | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,020 | 89 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
UGA | Uganda | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,021 | 91 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
UGA | Uganda | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,022 | 90 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
UGA | Uganda | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,023 | 91 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
UGA | Uganda | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,024 | 91 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TZA | United Republic of Tanzania | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,013 | 80 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TZA | United Republic of Tanzania | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,014 | 93 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TZA | United Republic of Tanzania | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,015 | 93 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TZA | United Republic of Tanzania | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,016 | 93 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TZA | United Republic of Tanzania | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,017 | 93 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TZA | United Republic of Tanzania | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,018 | 93 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TZA | United Republic of Tanzania | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,019 | 90 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TZA | United Republic of Tanzania | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,020 | 89 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TZA | United Republic of Tanzania | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,021 | 86 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TZA | United Republic of Tanzania | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,022 | 85 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TZA | United Republic of Tanzania | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,023 | 82 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
TZA | United Republic of Tanzania | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,024 | 82 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZMB | Zambia | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,014 | 77 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZMB | Zambia | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,015 | 81 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZMB | Zambia | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,016 | 94 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZMB | Zambia | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,017 | 94 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZMB | Zambia | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,018 | 90 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZMB | Zambia | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,019 | 89 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZMB | Zambia | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,020 | 85 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZMB | Zambia | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,021 | 89 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZMB | Zambia | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,022 | 87 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZMB | Zambia | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,023 | 87 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZMB | Zambia | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,024 | 91 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZWE | Zimbabwe | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,012 | 21 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZWE | Zimbabwe | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,013 | 95 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZWE | Zimbabwe | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,014 | 91 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZWE | Zimbabwe | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,015 | 87 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZWE | Zimbabwe | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,016 | 90 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZWE | Zimbabwe | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,017 | 89 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZWE | Zimbabwe | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,018 | 89 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZWE | Zimbabwe | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,019 | 90 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZWE | Zimbabwe | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,020 | 86 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZWE | Zimbabwe | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,021 | 88 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZWE | Zimbabwe | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,022 | 90 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZWE | Zimbabwe | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,023 | 90 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
ZWE | Zimbabwe | IM_PCV3 | Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV) | _T | Total | 2,024 | 91 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
DZA | Algeria | IM_POL3 | Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine | _T | Total | 1,981 | 31 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
DZA | Algeria | IM_POL3 | Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine | _T | Total | 1,982 | 31 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
DZA | Algeria | IM_POL3 | Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine | _T | Total | 1,983 | 30 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
DZA | Algeria | IM_POL3 | Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine | _T | Total | 1,984 | 30 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
DZA | Algeria | IM_POL3 | Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine | _T | Total | 1,985 | 69 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
DZA | Algeria | IM_POL3 | Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine | _T | Total | 1,986 | 72 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
DZA | Algeria | IM_POL3 | Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine | _T | Total | 1,987 | 79 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
DZA | Algeria | IM_POL3 | Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine | _T | Total | 1,988 | 85 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
DZA | Algeria | IM_POL3 | Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine | _T | Total | 1,989 | 87 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
DZA | Algeria | IM_POL3 | Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine | _T | Total | 1,990 | 89 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
DZA | Algeria | IM_POL3 | Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine | _T | Total | 1,991 | 89 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
DZA | Algeria | IM_POL3 | Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine | _T | Total | 1,992 | 88 | 0 | Units | PCNT | % | E | Estimated value | null | WHO/UNICEF estimates of national immunization coverage, 2024 revision | M12T23 | 12 to 23 months old |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.